Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

451 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First-generation epidermal growth factor receptor inhibitors in non-small cell lung cancer: clinical impact of the epidermal growth factor receptor fluorescence in situ hybridization assay.
Hirsch FR, Dziadziuszko R, Varella-Garcia M, Franklin WA, Gandara DR, Bunn PA Jr. Hirsch FR, et al. Among authors: gandara dr. J Thorac Oncol. 2008 Jun;3(6 Suppl 2):S138-42. doi: 10.1097/JTO.0b013e318174e922. J Thorac Oncol. 2008. PMID: 18520298 Free article. Review.
Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group.
Bunn PA Jr, Crowley J, Kelly K, Hazuka MB, Beasley K, Upchurch C, Livingston R, Weiss GR, Hicks WJ, Gandara DR, et al. Bunn PA Jr, et al. Among authors: gandara dr. J Clin Oncol. 1995 Jul;13(7):1632-41. doi: 10.1200/JCO.1995.13.7.1632. J Clin Oncol. 1995. PMID: 7602352 Clinical Trial.
Role of recombinant interferon alfa-2a maintenance in patients with limited-stage small-cell lung cancer responding to concurrent chemoradiation: a Southwest Oncology Group study.
Kelly K, Crowley JJ, Bunn PA Jr, Hazuka MB, Beasley K, Upchurch C, Weiss GR, Hicks WJ, Gandara DR, Rivkin S, et al. Kelly K, et al. Among authors: gandara dr. J Clin Oncol. 1995 Dec;13(12):2924-30. doi: 10.1200/JCO.1995.13.12.2924. J Clin Oncol. 1995. PMID: 8523056 Clinical Trial.
Multimodality therapy in stage III non-small cell lung cancer.
Edelman MJ, Gandara DR, Roach M 3rd, Benfield JR. Edelman MJ, et al. Among authors: gandara dr. Ann Thorac Surg. 1996 May;61(5):1564-72. doi: 10.1016/0003-4975(96)00044-6. Ann Thorac Surg. 1996. PMID: 8633990 Review.
Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial.
Kelly K, Crowley J, Bunn PA Jr, Presant CA, Grevstad PK, Moinpour CM, Ramsey SD, Wozniak AJ, Weiss GR, Moore DF, Israel VK, Livingston RB, Gandara DR. Kelly K, et al. Among authors: gandara dr. J Clin Oncol. 2001 Jul 1;19(13):3210-8. doi: 10.1200/JCO.2001.19.13.3210. J Clin Oncol. 2001. PMID: 11432888 Clinical Trial.
451 results